There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152511 | PMC |
| http://dx.doi.org/10.1007/s40256-020-00406-0 | DOI Listing |
Publication Analysis
Top Keywords
ras inhibitors
12
cardiovascular disease
8
renin-angiotensin system
8
inhibitors covid-19
8
covid-19
5
disease renin-angiotensin
4
inhibitors
4
system inhibitors
4
covid-19 ongoing
4
ongoing debate
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!